Long non-coding RNA MALAT1 and microRNA-499a expression profiles in diabetic ESRD patients undergoing dialysis: a preliminary cross-sectional analysis

References

• Adachi, T., et al., 2010. Plasma microRNA 499 as a biomarker of acute myocardial infarction. Clinical chemistry, 56 (7), 1183–1185.
   PubMed Web of Science ®Google Scholar
• Adhikary, L., et al., 2004. Abnormal p38 mitogen-activated protein kinase signalling in human and experimental diabetic nephropathy. Diabetologia, 47 (7), 1210–1222.
   PubMed Web of Science ®Google Scholar
• Al-Sayyari, A.A. and Shaheen, F.A., 2011. End stage chronic kidney disease in Saudi Arabia. A rapidly changing scene. Saudi Medical Journal, 32 (4), 339–346.
   PubMed Web of Science ®Google Scholar
• Altemtam, N., Russell, J., and El Nahas, M., 2012. A study of the natural history of diabetic kidney disease (DKD). Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association - European Renal Association, 27 (5), 1847–1854.
   PubMed Web of Science ®Google Scholar
• Ambros, V., 2004. The functions of animal microRNAs. Nature, 431 (7006), 350–355.
   PubMed Web of Science ®Google Scholar
• American Diabetes Association, 2014. Standards of medical care in diabetes –2014. Diabetes Care, 37 (Suppl. 1), S14–S80.
   PubMed Web of Science ®Google Scholar
• Arroyo, J.D., et al., 2011. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proceedings of the National Academy of Sciences of the United States of America, 108 (12), 5003–5008.
   PubMed Web of Science ®Google Scholar
• Bhat, S.A., et al., 2016. Long non-coding RNAs: mechanism of action and functional utility. Non-Coding RNA Research, 1 (1), 43–50.
   PubMedGoogle Scholar
• Bustin, S.A., et al., 2009. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clinical chemistry, 55 (4), 611–622.
   PubMed Web of Science ®Google Scholar
• Bustin, S.A., et al., 2013. The need for transparency and good practices in the qPCR literature. Nature methods, 10 (11), 1063–1067.
   PubMed Web of Science ®Google Scholar
• Cedervall, J., et al., 2017. Pharmacological targeting of peptidylarginine deiminase 4 prevents cancer-associated kidney injury in mice. OncoImmunology, 6 (8), e1320009.
   PubMed Web of Science ®Google Scholar
• Chen, S.C., et al., 2013. Association of dyslipidemia with renal outcomes in chronic kidney disease. PLoS One, 8 (2), e55643.
   PubMed Web of Science ®Google Scholar
• Corsten, M.F., et al., 2010. Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circulation. cardiovascular genetics, 3 (6), 499–506.
   PubMed Web of Science ®Google Scholar
• Deguchi, A., et al., 2013. Serum amyloid A3 binds MD-2 to activate p38 and NF-κB pathways in a MyD88-dependent manner. Journal of immunology (Baltimore, MD: 1950), 191 (4), 1856–1864.
   PubMed Web of Science ®Google Scholar
• DeLuca, A.J., et al., 2006. Comparison of prevalence of unrecognized myocardial infarction and of silent myocardial ischemia detected by a treadmill exercise sestamibi stress test in patients with versus without diabetes mellitus. American journal of cardiology, 98 (8), 1045–1046.
   PubMed Web of Science ®Google Scholar
• DiStefano, J.K., Taila, M., and Alvarez, M.L., 2013. Emerging roles for miRNAs in the development, diagnosis, and treatment of diabetic nephropathy. Current diabetes reports, 13 (4), 582–591.
   PubMed Web of Science ®Google Scholar
• Dodson, P.M., 2008. Medical treatment for diabetic retinopathy: Do the FIELD microvascular study results support a role for lipid lowering? Practical diabetes international, 25 (2), 76–79.
   Google Scholar
• Dumortier, O., Hinault, C., and Van Obberghen, E., 2013. MicroRNAs and metabolism crosstalk in energy homeostasis. Cell metabolism, 18 (3), 312–324.
   PubMed Web of Science ®Google Scholar
• Eckardt, K.U., et al., 2007. Hypoxia-inducible transcription factors and their role in renal disease. Seminars in nephrology, 27 (3), 363–372.
   PubMed Web of Science ®Google Scholar
• Emilian, C., et al., 2012. MicroRNAs in patients on chronic hemodialysis (MINOS study). Clinical journal of the American Society of Nephrology, 7 (4), 619–623.
   PubMed Web of Science ®Google Scholar
• Engreitz, J.M., et al., 2014. RNA-RNA interactions enable specific targeting of noncoding RNAs to nascent pre-mRNAs and chromatin sites. Cell, 159 (1), 188–199.
   PubMed Web of Science ®Google Scholar
• Fawzy, M.S., Toraih, E.A., and Abdallah, H.Y., 2017. Long noncoding RNA Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1): A molecular predictor of poor survival in glioblastoma multiforme in Egyptian patients. Egyptian journal of medical human genetics, 18 (3), 231–239.
   Google Scholar
• Fawzy, M.S., et al., 2018. Association of MIR-499a expression and seed region variant (rs3746444) with cardiovascular disease in Egyptian patients. Acta cardiologica, 73 (2), 131–140.
   PubMed Web of Science ®Google Scholar
• Fernandez-Hernando, C., et al., 2013. MicroRNAs in metabolic disease. Arteriosclerosis, thrombosis, and vascular biology, 33 (2), 178–185.
   PubMed Web of Science ®Google Scholar
• Frieldewald, W.T., Levy, R.I., and Fredrickson, D.S., 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical chemistry, 18 (6), 499–502.
   PubMed Web of Science ®Google Scholar
• Gidlöf, O., et al., 2011. Cardiospecific microRNA plasma levels correlate with troponin and cardiac function in patients with ST elevation myocardial infarction, are selectively dependent on renal elimination and can be detected in urine samples. Cardiology, 118 (4), 217–226.
   PubMed Web of Science ®Google Scholar
• Gödel, M., et al., 2011. Role of mTOR in podocyte function and diabetic nephropathy in humans and mice. The journal of clinical investigation, 121 (6), 2197–2209.
   PubMed Web of Science ®Google Scholar
• Gomes, A.Q., Nolasco, S., and Soares, H., 2013. Non-coding RNAs: multi-tasking molecules in the cell. International journal of molecular sciences, 14 (8), 16010–16039.
   PubMed Web of Science ®Google Scholar
• Greco, S., Gorospe, M., and Martelli, F., 2015. Noncoding RNA in age-related cardiovascular diseases. Journal of molecular and cellular cardiology, 83, 142–155.
   PubMed Web of Science ®Google Scholar
• Grzegorzewska, A.E., et al., 2014. T-cell cytokine gene polymorphisms and vitamin D pathway gene polymorphisms in end-stage renal disease due to type 2 diabetes mellitus nephropathy: comparisons with health status and other main causes of end-stage renal disease. Journal of diabetes research, 2014, 120317.
   PubMedGoogle Scholar
• Gutschner, T., Hämmerle, M., and Diederichs, S., 2013. MALAT1 – a paradigm for long noncoding RNA function in cancer. Journal of molecular medicine (Berlin, Germany), 91 (7), 791–801.
   PubMed Web of Science ®Google Scholar
• Ha, T.-Y., 2011. MicroRNAs in human diseases: from cancer to cardiovascular disease. Immune Network, 11 (3), 135–154.
   PubMedGoogle Scholar
• Hüttenhofer, A. and Mayer, G., 2017. Circulating miRNAs as biomarkers of kidney disease. Clinical kidney journal, 10 (1), 27–29.
   PubMed Web of Science ®Google Scholar
• Jalali, S., et al., 2013. Systematic transcriptome wide analysis of lncRNA-miRNA interactions. PLoS One, 8 (2), e53823.
   PubMed Web of Science ®Google Scholar
• Jeggari, A., Marks, D.S., and Larsson, E., 2012. miRcode: a map of putative microRNA target sites in the long non-coding transcriptome. Bioinformatics, 28 (15), 2062–2063.
   PubMed Web of Science ®Google Scholar
• Ji, P., et al., 2003. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene, 22 (39), 8031–8041.
   PubMed Web of Science ®Google Scholar
• Johnson, R.J., et al., 2013. Uric acid and chronic kidney disease: which is chasing which?. Nephrology, dialysis, transplantation: Official publication of the European Dialysis and Transplant Association – European Renal Association, 28 (9), 2221–2228.
   PubMed Web of Science ®Google Scholar
• Ka, S.M., et al., 2012. Kidney-targeting Smad7 gene transfer inhibits renal TGF-β/MAD homologue (SMAD) and nuclear factor κb (NF-κB) signalling pathways, and improves diabetic nephropathy in mice. Diabetologia, 55 (2), 509–519.
   PubMed Web of Science ®Google Scholar
• Keane, W.F., Tomassini, J.E., and Neff, D.R., 2013. Lipid abnormalities in patients with chronic kidney disease: implications for the pathophysiology of atherosclerosis. Journal of atherosclerosis and thrombosis, 20 (2), 123–133.
   PubMed Web of Science ®Google Scholar
• Kern, T.S., 2007. Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Experimental diabetes research, 2007, 95103.
   PubMed Web of Science ®Google Scholar
• Khanaghaei, M., et al., 2016. Circulating miR-126 and miR-499 reflect progression of cardiovascular disease; correlations with uric acid and ejection fraction. Heart international, 11 (1), e1–e9.
   PubMed Web of Science ®Google Scholar
• Kronenberg, F., 2009. Emerging risk factors and markers of chronic kidney disease progression. Nature reviews nephrology, 5 (12), 677–689.
   PubMed Web of Science ®Google Scholar
• Lelli, A., et al., 2015. Induction of long noncoding RNA MalaT1 in hypoxic mice. Hypoxia (Auckland, N.Z.), 3, 45–52.
   PubMed Web of Science ®Google Scholar
• Li, J., et al., 2016. Long noncoding RNAs regulate cell growth, proliferation, and apoptosis. DNA and cell biology, 35 (9), 459–470.
   PubMed Web of Science ®Google Scholar
• Lim, A.K., 2014. Diabetic nephropathy – complications and treatment. International journal of nephrology and renovascular disease, 7, 361–381.
   PubMedGoogle Scholar
• Livak, K.J. and Schmittgen, T.D., 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (San Diego, California), 25 (4), 402–408.
   PubMed Web of Science ®Google Scholar
• Lu, Z., Liu, N., and Wang, F., 2017. Epigenetic regulations in diabetic nephropathy. Journal of diabetes research, 2017, 7805058.
   PubMed Web of Science ®Google Scholar
• Ma, X.Y., et al., 2015. MALAT1 as an evolutionarily conserved lncRNA, plays a positive role in regulating proliferation and maintaining undifferentiated status of early-stage hematopoietic cells. BMC genomics, 16 (1), 676.
   PubMedGoogle Scholar
• Martino, F., et al., 2012. Circulating microRNAs are not eliminated by hemodialysis. PLoS one, 7 (6), e38269.
   PubMed Web of Science ®Google Scholar
• Michalik, K.M., et al., 2014. Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth. Circulation research, 114 (9), 1389–1397.
   PubMed Web of Science ®Google Scholar
• Mooyaart, A.L., 2014. Genetic associations in diabetic nephropathy. Clinical and experimental nephrology, 18 (2), 197–200.
   PubMed Web of Science ®Google Scholar
• Mooyaart, A.L., et al., 2011. Genetic associations in diabetic nephropathy: a meta-analysis. Diabetologia, 54 (3), 544–553.
   PubMed Web of Science ®Google Scholar
• Muntner, P., et al., 2000. Plasma lipids and risk of developing renal dysfunction: the atherosclerosis risk in communities study. Kidney international, 58 (1), 293–301.
   PubMed Web of Science ®Google Scholar
• Nangaku, M., 2006. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. Journal of the American Society of Nephrology, 17 (1), 17–25.
   PubMed Web of Science ®Google Scholar
• Neal, C.S., et al., 2011. Circulating microRNA expression is reduced in chronic kidney disease. Nephrology, dialysis, transplantation: official publication of the European Dialysis and Transplant Association – European Renal Association, 26 (11), 3794–3802.
   PubMed Web of Science ®Google Scholar
• Penno, G., et al., 2015. Hypertriglyceridemia is independently associated with renal, but not retinal complications in subjects with type 2 diabetes: a cross-sectional analysis of the renal insufficiency and cardiovascular events (RIACE) Italian multicenter study. PLoS One, 10 (5), e0125512.
   PubMed Web of Science ®Google Scholar
• Puthanveetil, P., et al., 2015. Long non-coding RNA MALAT1 regulates hyperglycemia induced inflammatory process in the endothelial cells. Journal of cellular and molecular medicine, 19 (6), 1418–1425.
   PubMed Web of Science ®Google Scholar
• Qian, Y., et al., 2008. From fibrosis to sclerosis: mechanisms of glomerulosclerosis in diabetic nephropathy. Diabetes, 57 (6), 1439–1445.
   PubMed Web of Science ®Google Scholar
• Raffort, J., et al., 2015. Circulating micro RNAs and diabetes: potential applications in medical practice. Diabetologia, 58 (9), 1978–1992.
   PubMed Web of Science ®Google Scholar
• Rashid, F., Shah, A., and Shan, G., 2016. Long non-coding RNAs in the cytoplasm. Genomics, proteomics and bioinformatics, 14 (2), 73–80.
   PubMed Web of Science ®Google Scholar
• Reeves, W.B. and Andreoli, T.E., 2000. Transforming growth factor beta contributes to progressive diabetic nephropathy. Proceedings of the National Academy of Sciences of the United States of America, 97 (14), 7667–7669.
   PubMed Web of Science ®Google Scholar
• Retnakaran, R., et al., 2006. Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74. Diabetes, 55 (6), 1832–1839.
   PubMed Web of Science ®Google Scholar
• Sakai, N., et al., 2005. Involvement of extracellular signal-regulated kinase and p38 in human diabetic nephropathy. American journal of kidney diseases: the official journal of the National Kidney Foundation, 45 (1), 54–65.
   PubMed Web of Science ®Google Scholar
• Sallé-Lefort, S., et al., 2016. Hypoxia upregulates MALAT1 expression through a CaMKK/AMPK/HIF-1α axis. International journal of oncology, 49 (4), 1731–1736.
   PubMed Web of Science ®Google Scholar
• Sattar, A., et al., 2012. All-cause and cause-specific mortality associated with diabetes in prevalent hemodialysis patients. BMC nephrology, 13, 130
   PubMed Web of Science ®Google Scholar
• Schmid, T., et al., 2004. p300 relieves p53-evoked transcriptional repression of hypoxia-inducible factor-1 (HIF-1). The biochemical journal, 380 (Pt 1), 289–295.
   PubMedGoogle Scholar
• Serino, G., Sallustio, F., and Schena, F., P., 2016. MicroRNAs in kidney diseases. In: V.B. Patel and V.R. Preedy, eds. Biomarkers in kidney disease. Dordrecht: Springer, 107–138.
   Google Scholar
• Sermeus, A. and Michiels, C., 2011. Reciprocal influence of the p53 and the hypoxic pathways. Cell Death and Disease, 2, e164.
   PubMed Web of Science ®Google Scholar
• Shuai, P., et al., 2016. Long noncoding RNA MALAT1 can serve as a valuable biomarker for prognosis and lymph node metastasis in various cancers: a meta-analysis. SpringerPlus, 5 (1), 1721.
   PubMedGoogle Scholar
• Singh, K.K., et al., 2016. Investigation of TGFβ1-induced long noncoding RNAs in endothelial cells. International journal of vascular medicine, 2016, 2459687.
   PubMedGoogle Scholar
• Sluijter, J.P., et al., 2010. MicroRNA-1 and -499 regulate differentiation and proliferation in human-derived cardiomyocyte progenitor cells. Arteriosclerosis, thrombosis, and vascular biology, 30 (4), 859–868.
   PubMed Web of Science ®Google Scholar
• Spector, D.L. and Lamond, A.I., 2011. Nuclear speckles. Cold spring harbor perspectives in biology, 3 (2), a000646.
   PubMed Web of Science ®Google Scholar
• Takiyama, Y. and Haneda, M., 2014. Hypoxia in diabetic kidneys. BioMed research international, 2014, 837421.
   PubMedGoogle Scholar
• Thomas, M.C., et al., 2015. Diabetic kidney disease. Nature reviews. disease primers, 1, 15018.
   PubMed Web of Science ®Google Scholar
• Toraih, E.A., et al., 2015. Pilot study of serum MicroRNA-21 as a diagnostic and prognostic biomarker in egyptian breast cancer patients. Molecular diagnosis and therapy, 19 (3), 179–190.
   PubMed Web of Science ®Google Scholar
• Toraih, E.A., et al., 2016. MicroRNA-196a2 biomarker and targetome network analysis in solid tumors. Molecular diagnosis and therapy, 20 (6), 559–577.
   PubMed Web of Science ®Google Scholar
• Tripathi, V., et al., 2010. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Molecular cell, 39 (6), 925–938.
   PubMed Web of Science ®Google Scholar
• Tripathi, V., et al., 2013. Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB. PLoS genetics, 9 (3), e1003368.
   PubMed Web of Science ®Google Scholar
• Vickers, K.C., et al., 2011. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nature cell biology, 13 (4), 423–433.
   PubMed Web of Science ®Google Scholar
• Wang, J.-X., et al., 2011. miR-499 Regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1. Nature medicine, 17 (1), 71–78.
   PubMed Web of Science ®Google Scholar
• Wang, K.C. and Chang, H.Y., 2011. Molecular mechanisms of long noncoding RNAs. Molecular cell, 43 (6), 904–914.
   PubMed Web of Science ®Google Scholar
• Watts, R., et al., 2013. Myostatin-induced inhibition of the long noncoding RNA Malat1 is associated with decreased myogenesis. American journal of physiology. Cell physiology, 304 (10), C995–C1001.
   PubMed Web of Science ®Google Scholar
• Wong, S.L., et al., 2015. Diabetes primes neutrophils to undergo NETosis, which impairs wound healing. Nature medicine, 21 (7), 815–819.
   PubMed Web of Science ®Google Scholar
• Wu, C.C., et al., 2011. Role of T cells in type 2 diabetic nephropathy. Experimental diabetes research, 2011, 514738.
   PubMedGoogle Scholar
• Wu, H., et al., 2014. The role of MicroRNAs in diabetic nephropathy. Journal of diabetes research, 2014, 920134.
   PubMed Web of Science ®Google Scholar
• Xu, W., et al., 2013. Differential expression of genes associated with the progression of renal disease in the kidneys of liver-specific glucokinase gene knockout mice. International journal of molecular sciences, 14 (3), 6467–6486.
   PubMed Web of Science ®Google Scholar
• Yan, B., et al., 2014. Aberrant expression of long noncoding RNAs in early diabetic retinopathy. Investigative opthalmology and visual science, 55 (2), 941–951.
   PubMed Web of Science ®Google Scholar
• Yan, B., et al., 2015a. lncRNA-MIAT regulates microvascular dysfunction by functioning as a competing endogenous RNA novelty and significance. Circulation research, 116 (7), 1143–1156.
   PubMed Web of Science ®Google Scholar
• Yan, D., et al., 2015b. Uric acid is independently associated with diabetic kidney disease: a cross-sectional study in a Chinese population. PLoS One, 10 (6), e0129797.
   PubMed Web of Science ®Google Scholar
• Yang, B., et al., 2011. Association study of single nucleotide polymorphisms in pre-miRNA and rheumatoid arthritis in a Han Chinese population. Molecular biology reports, 38 (8), 4913–4919.
   PubMed Web of Science ®Google Scholar
• Yoon, J.-H., Abdelmohsen, K., and Gorospe, M., 2013. Posttranscriptional gene regulation by long noncoding RNA. Journal of molecular biology, 425 (19), 3723–3730.
   PubMed Web of Science ®Google Scholar
• Zacharewicz, E., et al., 2014. Identification of MicroRNAs linked to regulators of muscle protein synthesis and regeneration in young and old skeletal muscle. PLoS One, 9 (12), e114009.
   PubMed Web of Science ®Google Scholar
• Zarjou, A., et al., 2011. Identification of a microRNA signature in renal fibrosis: role of miR-21. American journal of physiology. Renal physiology, 301 (4), F793–F801.
   PubMed Web of Science ®Google Scholar
• Zhang, B., et al., 2012. The lncRNA Malat1 is dispensable for mouse development but its transcription plays a cis-regulatory role in the adult. Cell reports, 2 (1), 111–123.
   PubMed Web of Science ®Google Scholar
• Zhou, C.H., et al., 2015. Modeling the interplay between the HIF-1 and p53 pathways in hypoxia. Scientific reports, 5, 13834.
   PubMed Web of Science ®Google Scholar